1-173912755-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000488.4(SERPINC1):​c.409-741G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0998 in 152,066 control chromosomes in the GnomAD database, including 937 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. The gene SERPINC1 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.10 ( 937 hom., cov: 32)

Consequence

SERPINC1
NM_000488.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.167

Publications

6 publications found
Variant links:
Genes affected
SERPINC1 (HGNC:775): (serpin family C member 1) The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Sep 2020]
SERPINC1 Gene-Disease associations (from GenCC):
  • hereditary antithrombin deficiency
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000488.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPINC1
NM_000488.4
MANE Select
c.409-741G>A
intron
N/ANP_000479.1P01008
SERPINC1
NM_001386302.1
c.409-741G>A
intron
N/ANP_001373231.1
SERPINC1
NM_001386303.1
c.490-741G>A
intron
N/ANP_001373232.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPINC1
ENST00000367698.4
TSL:1 MANE Select
c.409-741G>A
intron
N/AENSP00000356671.3P01008
SERPINC1
ENST00000874328.1
c.409-741G>A
intron
N/AENSP00000544387.1
SERPINC1
ENST00000874324.1
c.409-741G>A
intron
N/AENSP00000544383.1

Frequencies

GnomAD3 genomes
AF:
0.0998
AC:
15165
AN:
151948
Hom.:
937
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0641
Gnomad AMI
AF:
0.101
Gnomad AMR
AF:
0.0866
Gnomad ASJ
AF:
0.158
Gnomad EAS
AF:
0.308
Gnomad SAS
AF:
0.141
Gnomad FIN
AF:
0.105
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.102
Gnomad OTH
AF:
0.112
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0998
AC:
15172
AN:
152066
Hom.:
937
Cov.:
32
AF XY:
0.102
AC XY:
7569
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.0640
AC:
2657
AN:
41506
American (AMR)
AF:
0.0865
AC:
1321
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.158
AC:
547
AN:
3472
East Asian (EAS)
AF:
0.308
AC:
1594
AN:
5168
South Asian (SAS)
AF:
0.141
AC:
680
AN:
4818
European-Finnish (FIN)
AF:
0.105
AC:
1105
AN:
10568
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.102
AC:
6902
AN:
67948
Other (OTH)
AF:
0.114
AC:
240
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
714
1427
2141
2854
3568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0948
Hom.:
157
Bravo
AF:
0.0966
Asia WGS
AF:
0.220
AC:
764
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.9
DANN
Benign
0.41
PhyloP100
-0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs941988; hg19: chr1-173881893; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.